Bloomberg News

Given Rises to 5-Month High as Patients Enroll in Pillcam Trial

January 04, 2012

Jan. 4 (Bloomberg) -- Given Imaging Ltd. advanced to the highest in more than five months after the maker of a pill-sized camera to diagnose digestive ailments said about 700 patients have enrolled in a PillCam COLON 2 trial.

The shares gained 2.2 percent to 69.21 shekels, the highest intraday level since July 27, at 3:48 p.m. in Tel Aviv.

--Editors: Daliah Merzaban, Shanthy Nambiar

To contact the reporter on this story: Shoshanna Solomon in Tel Aviv at ssolomon22@bloomberg.net

To contact the editor responsible for this story: Claudia Maedler at cmaedler@bloomberg.net


The Good Business Issue
LIMITED-TIME OFFER SUBSCRIBE NOW
 
blog comments powered by Disqus